These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37997278)

  • 1. Navigating the landscape of psoriasis therapy: novel targeted pathways and emerging trends.
    Innani S; Tomar Y; Rana V; Singhvi G
    Expert Opin Ther Targets; 2023; 27(12):1247-1256. PubMed ID: 37997278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural Product-Derived Compounds Targeting Keratinocytes and Molecular Pathways in Psoriasis Therapeutics.
    Lee YG; Jung Y; Choi HK; Lee JI; Lim TG; Lee J
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis.
    Schaper K; Dickhaut J; Japtok L; Kietzmann M; Mischke R; Kleuser B; Bäumer W
    J Dermatol Sci; 2013 Jul; 71(1):29-36. PubMed ID: 23643308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging trends in combination strategies with phototherapy in advanced psoriasis management.
    Sreya R; Nene S; Pathade V; Singh SB; Srivastava S
    Inflammopharmacology; 2023 Aug; 31(4):1761-1778. PubMed ID: 37326755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging landscape in psoriasis management: From topical application to targeting biomolecules.
    Rapalli VK; Singhvi G; Dubey SK; Gupta G; Chellappan DK; Dua K
    Biomed Pharmacother; 2018 Oct; 106():707-713. PubMed ID: 29990862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the pivotal role of signaling pathways in psoriasis pathogenesis, potential therapeutic molecules and drug delivery approaches.
    Tomar Y; Gorantla S; Singhvi G
    Drug Discov Today; 2023 Feb; 28(2):103465. PubMed ID: 36481585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New drugs and treatment targets in psoriasis.
    Kofoed K; Skov L; Zachariae C
    Acta Derm Venereol; 2015 Feb; 95(2):133-9. PubMed ID: 25111317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologics and Small Molecule Agents in Allergic and Immunologic Skin Diseases.
    Kaufman BP; Alexis AF
    Curr Allergy Asthma Rep; 2018 Aug; 18(10):55. PubMed ID: 30171358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis.
    Woo YR; Cho DH; Park HJ
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and Under Development Treatment Modalities of Psoriasis: A Review.
    Albaghdadi A
    Endocr Metab Immune Disord Drug Targets; 2017; 17(3):189-199. PubMed ID: 28782467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and Future Trends in the Treatment of Psoriasis.
    Lee HJ; Kim M
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Sphingolipids and Sphingosine-1-phosphate-Sphingosine-1-phosphate-receptor Signaling in Psoriasis.
    Masuda-Kuroki K; Alimohammadi S; Di Nardo A
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspective insights of small molecules, phytoconstituents and biologics in the management of psoriasis: A focus on targeting major inflammatory cytokine pathways.
    Kadagothy H; Nene S; Amulya E; Vambhurkar G; Rajalakshmi AN; Khatri DK; Singh SB; Srivastava S
    Eur J Pharmacol; 2023 May; 947():175668. PubMed ID: 36958476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in nanotechnology-based delivery systems for dermal targeting of drugs: an enticing approach to offset psoriasis.
    Saleem S; Iqubal MK; Garg S; Ali J; Baboota S
    Expert Opin Drug Deliv; 2020 Jun; 17(6):817-838. PubMed ID: 32315216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-immune functions of inflammatory cytokines targeted by anti-psoriatic biologics: a review.
    Lee TL; Tsai TF
    Inflamm Res; 2022 Feb; 71(2):157-168. PubMed ID: 34981130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic or Antiproliferative Activity of Natural Products against Keratinocytes for the Treatment of Psoriasis.
    Huang TH; Lin CF; Alalaiwe A; Yang SC; Fang JY
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in psoriasis research: From pathogenesis to therapeutics.
    Sugumaran D; Yong ACH; Stanslas J
    Life Sci; 2024 Oct; 355():122991. PubMed ID: 39153596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis: implication to disease and therapeutic strategies, with an emphasis on drug delivery approaches.
    Todke P; Shah VH
    Int J Dermatol; 2018 Nov; 57(11):1387-1402. PubMed ID: 29923192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and emerging systemic treatment strategies for psoriasis.
    Laws PM; Young HS
    Drugs; 2012 Oct; 72(14):1867-80. PubMed ID: 22938141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.